Myriad Genetics (MYGN): SOTP Suggesting The Company Is Undervalued (NASDAQ:MYGN)

Core Insights - Seeking Alpha welcomes Vatsal Garg as a new contributing analyst, emphasizing the platform's commitment to diverse investment perspectives and research-driven ideas [1] Group 1: Analyst Profile - The analyst specializes in event-driven opportunities, activist special situations, and global macro investing, managing an independent portfolio across various asset classes [2] - The investment process includes fundamental analysis, discounted cash flow (DCF), sum-of-the-parts (SOTP) modeling, governance analysis, and financial restructuring assessments [2] - Research interests cover activist equities, macro-thematic positioning through ETFs, and selective short-selling opportunities, focusing on structural weaknesses or mispricing [2] Group 2: Research Focus - The analyst aims to write about special situations, event-driven investments, macro themes, portfolio strategy, and ETF-based positioning [2] - The focus is on industries where corporate actions, balance sheet transformations, or macro shifts create potential valuation dislocations [2] - The analyst holds advanced degrees in Corporate Finance and Business Management, with a background in writing multiple books on investment strategies [2]